Cholangioscopy Market Size, Share, Opportunities, And Trends By Type (Peroral Videocholangioscopy (POCS), Direct Peroral Videocholangioscopy (D-POCS), SpyGlass™ Direct Visualization System (SGDVS), Others), By Equipment Type (Endoscope, Duodenoscope, Others), By Application (Diagnostics (Post–liver transplant, Choledocholithiasis, Intraductal tumor mapping, Others), Therapeutics (Lithotripsy, Biliary tumor ablative therapy, Selective biliary duct wire cannulation), By Technology (High Definition Systems, Digital Imaging Technologies), By End User (Hospitals, Surgical Centers) And By Geography - Forecasts From 2025 To 2030

Cholangioscopy Market Size

The cholangioscopy market is estimated to grow at a CAGR of 7.19%, attaining US$14.820 billion by 2030, from US$10.476 billion in 2025.

Cholangioscopy or peroral cholangioscopy (POC) is a type of low or minimal-invasive procedure, that is commonly used to evaluate or diagnose the bile ducts of the patients. The cholangioscopy procedure is majorly used for direct visual diagnostic evaluation of the bile ducts or for simultaneous therapeutic intervention. The process offers multiple benefits to the healthcare sector, which include identifying and addressing blockages in the liver, pancreatic, and biliary parts of the body, and is also used to spot or identify cancer in the ducts.

The global cholangioscopy market is expected to witness significant growth majorly with the increasing global cases of bile duct cancer during the forecasted timeline. The cholangioscopy plays a critical role in detecting and monitoring bile duct cancer. Similarly, the increasing global older population is also expected to boost the growth of the global cholangioscopy market. The risk of side effects and the expensive procedure of cholangioscopy are among the key factors challenging the growth of the market.

Cholangioscopy Market Growth Drivers:

• Increasing global cases of bile duct cancer.

The major factor propelling the growth of the global cholangioscopy market is the increasing global cases of bile duct cancer. Bile duct cancer or cholangiocarcinoma is a type of rare and more aggressive form of cancer, which is more common in the older population. Cholangioscopy offers a critical role in detecting and assessing the details of malignant spots, which helps in monitor and locate precise location of the cancer cell. The cholangioscopy procedure can also be helpful in collecting specimens of the cancer cell which can help enhance the process of therapy.

The global cases of bile duct cancer witnessed significant growth during the past few years. The American Cancer Society, in its report, stated that in the USA, about 8,000 new cases of bile duct cancer are diagnosed annually. Similarly, the Christie NHS Foundation Trust of the UK, stated that in the nation, about 1,000 cases of bile duct cancer are recorded annually.

• Increasing global older population.

The increasing population of the older population across the globe is also among the key factors propelling the growth of the cholangioscopy market, during the forecasted timeline. With the increasing age of an individual, the cases of various types of cholangioscopy diseases, like bile duct blockage, cholangitis, duct strictures, and pancreatic duct stones increase. Various medical research institutes across the globe stated that in the older population, cases of cholangioscopy or bile duct cancer are most common.

The global older population witnessed a significant surge during the past few years. The World Bank, in its report, stated that in 2021, the population above the age of 65 years recorded at 754.681 million, which surged to 778.122 million in 2022. In 2023, the total population above the age of 65 years was recorded at 805.475 million. In 2022, the total population of males above the age of 65 years was recorded at 345.650 million, whereas the population of females was recorded at 432.471 million. Similarly, in 2023, the total population of males above the age of 65 years was recorded at 357.583 million, whereas the female population was recorded at 446.891 million.

• Increasing investment in the medical technology and devices sector.

The increasing investment and introduction of key governmental policies to boost the medical equipment technoilogy across the globe is also expected to propel the growth of the market during the forecasted period. Various countries, like the USA, Canada, India, and Japan have introduced key policies and investment opportunities to boost the advancement of medical device technologies. For instance, the Department of Pharmaceuticals of the Indian Government, in April 2023, announced the introduction of the National Medical Device Policy, which is designed to accelerate the development of the patient-centric medical device technology approach. The policy also aims to boost innovation and competitiveness in the global medical device technology market.

Cholangioscopy Market Restraint:

• Risk of side effects to the procedure

The major challenging factor to the growth of the global cholangioscopy market is the increasing risk of side effects related to preoral cholangioscopy. The procedure of cholangioscopy involves various types of side effects to the patients, which include stomach upset, vomiting, drowsiness, and sore throat among others. Preoral cholangioscopy can also lead to intestinal gas and bloating, or cramping of the stomach, as the procedure traps a small amount of air in the stomach.

• Expensive process of cholangioscopy

The cholangioscopy procedure involves integrations of various medical procedures, which include anesthesiology and endoscopy among others. The first step of the cholangioscopy procedure is anesthesia, which can cause drowsiness in the patients, followed by placing a mouth guard, and carefully guiding the endoscope or duodenoscope through the throat. The process of cholangioscopy requires well-trained endoscopists, making the procedure expensive.

Cholangioscopy Market Scope:

• North American is forecasted to hold a major share of the cholangioscopy market.

The North American region is expected to witness a major growth in the global cholangioscopy makret, during the forecasted timeline, majorly with the increasing adoption of advanced technologies into the healthcare sector.

The North American region is also among the leading market in the research and development of enhanced technologies, that is expected to boost the performance of the cholangioscopic equipment. Similarly, countries like the USA and Canada in the region have also introduced key policies and investment opportunities to enhanced the reach of advanced technologies in the pharmaceutical sector.

Cholangioscopy Market Products Offered by Key Companies:

• Micro-Tech Endoscopy is a global leader in manufacturing, researcher, and developer of minimally invasive medical devices. The company offers a wide range of medical equipment and products, which includes solutions for biopsy, dilation, biliary, EMR-ESD, infection prevention, EUS needles, nitinol stents, and necrosectomy among others. In the global cholangioscopy market, the company offers multiple types of products and equipment, like Eyemax, Walz EHL, and Eyemax 650 series scopes.
• Boston Scientific Corporation is an American-based, biotechnology and biomedicine leader, that offers a wide range of products and solutions in the healthcare sector. In the global market, the company offers a wide range of products and solutions for multiple therapeutic categories, which include electrophysiology, gastroenterology, gynecology, otolaryngology, and neurological surgery among others. In the global cholangioscopy market, the company offers Spyglass DS, a type of direct visualization system, that offers an efficient diagnosis and treatment of biliary stricture and gallstones.

Cholangioscopy Market Key Developments:

• In January 2024, HCG KLE Suchirayu Hospital, a super specialty hospital in India, announced that the team of doctors of the hospital treated the common bile duct, or CBD stone, of a 60-year-old man, using a complex Spy Cholangioscopy procedure.

Cholangioscopy Market Scope:

Report Metric	Details
Cholangioscopy Market Size in 2025	US$10.476 billion
Cholangioscopy Market Size in 2030	US$14.820 billion
Growth Rate	CAGR of 7.19%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Type Equipment Type Application End User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Cholangioscopy Market	Boston Scientific Corporation Micro-Tech Endoscopy Japan Lifeline Co., Ltd. Ottomed Olympus Corporation
Customization Scope	Free report customization with purchase

 

The Cholangioscopy Market is analyzed into the following segments:

• By Type
  • Peroral Videocholangioscopy (POCS)
  • Direct Peroral Videocholangioscopy (D-POCS)
  • SpyGlass™ Direct Visualization System (SGDVS)
  • Others
• By Equipment Type
  • Endoscope
  • Duodenoscope
  • Others
• By Application
  • Diagnostics
    • Post–liver transplant
    • Choledocholithiasis
    • Intraductal tumor mapping
    • Others
  • Therapeutics
    • Lithotripsy
    • Biliary tumor ablative therapy
    • Selective biliary duct wire cannulation
• By Technology
  • High Definition Systems
  • Digital Imaging Technologies
• By End User
  • Hospitals
  • Surgical Centers
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific Region
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. The Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. CHOLANGIOSCOPY SAUCE MARKET BY TYPE

5.1. Introduction

5.2. Peroral Videocholangioscopy (POCS)

5.3. Direct Peroral Videocholangioscopy (D-POCS)

5.4. SpyGlass Direct Visualization System (SGDVS)

5.5. Others

6. CHOLANGIOSCOPY SAUCE MARKET BY EQUIPMENT TYPE

6.1. Introduction

6.2. Endoscope

6.3. Duodenoscope

6.4. Others

7. CHOLANGIOSCOPY MARKET BY APPLICATION 

7.1. Introduction

7.2. Diagnostics

7.2.1. Post–liver transplant

7.2.2. Choledocholithiasis

7.2.3. Intraductal tumor mapping

7.2.4. Others

7.3. Therapeutics

7.3.1. Lithotripsy

7.3.2. Biliary tumor ablative therapy

7.3.3. Selective biliary duct wire cannulation

7.3.4. Others

8. CHOLANGIOSCOPY MARKET BY TECHNOLOGY

8.1. Introduction

8.2. High Definition Systems

8.3. Digital Imaging Technologies

9. CHOLANGIOSCOPY MARKET BY END-USER

9.1. Introduction

9.2. Hospitals

9.3. Surgical Centers

10. CHOLANGIOSCOPY MARKET BY GEOGRAPHY

10.1. Introduction

10.2. North America

10.2.1. By Type

10.2.2. By Equipment Type

10.2.3. By Application

10.2.4. By Technology

10.2.5. By End-User

10.2.6. By Country

10.2.6.1. United States

10.2.6.2. Canada

10.2.6.3. Mexico

10.3. South America

10.3.1. By Type

10.3.2. By Equipment Type

10.3.3. By Application

10.3.4. By Technology

10.3.5. By End-User

10.3.6. By Country

10.3.6.1. Brazil

10.3.6.2. Argentina

10.3.6.3. Others

10.4. Europe

10.4.1. By Type

10.4.2. By Equipment Type

10.4.3. By Application

10.4.4. By Technology

10.4.5. By End-User

10.4.6. By Country

10.4.6.1. Germany

10.4.6.2. Spain

10.4.6.3. United Kingdom

10.4.6.4. France

10.4.6.5. Others

10.5. Middle East and Africa

10.5.1. By Type

10.5.2. By Equipment Type

10.5.3. By Application

10.5.4. By Technology

10.5.5. By End-User

10.5.6. By Country

10.5.6.1. Saudi Arabia

10.5.6.2. UAE

10.5.6.3. Israel

10.5.6.4. Others

10.6. Asia Pacific

10.6.1. By Type

10.6.2. By Equipment Type

10.6.3. By Application

10.6.4. By Technology

10.6.5. By End-User

10.6.6. By Country

10.6.6.1. Japan

10.6.6.2. China

10.6.6.3. India

10.6.6.4. South Korea

10.6.6.5. Indonesia

10.6.6.6. Thailand

10.6.6.7. Taiwan

10.6.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

11.1. Major Players and Strategy Analysis

11.2. Market Share Analysis

11.3. Mergers, Acquisitions, Agreements, and Collaborations

11.4. Competitive Dashboard

12. COMPANY PROFILES

12.1. Boston Scientific Corporation

12.2. Micro-Tech Endoscopy

12.3. Japan Lifeline Co., Ltd.

12.4. Ottomed

12.5. Olympus Corporation

12.6. Penlon

12.7. Fujifilm Group

12.8. Medtronic

12.9. Johnson & Johnson

12.10. Cook Medical, Inc.

12.11. B. Braun Melsungen AG

12.12. Arthrex, Inc.

12.13. HOYA Corporation

Boston Scientific Corporation 

Micro-Tech Endoscopy 

Japan Lifeline Co., Ltd. 

Ottomed 

Olympus Corporation 

Penlon 

Fujifilm Group 

Medtronic 

Johnson & Johnson 

Cook Medical, Inc. 

B. Braun Melsungen AG 

Arthrex, Inc. 

HOYA Corporation